CA2241788A1 - Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them - Google Patents

Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them

Info

Publication number
CA2241788A1
CA2241788A1 CA002241788A CA2241788A CA2241788A1 CA 2241788 A1 CA2241788 A1 CA 2241788A1 CA 002241788 A CA002241788 A CA 002241788A CA 2241788 A CA2241788 A CA 2241788A CA 2241788 A1 CA2241788 A1 CA 2241788A1
Authority
CA
Canada
Prior art keywords
arylsulphonyl
novel
amino acid
pharmaceutical compositions
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002241788A
Other languages
French (fr)
Other versions
CA2241788C (en
Inventor
Bernard Ferrari
Jean Gougat
Claude Muneaux
Yvette Muneaux
Pierre Perreaut
Claudine Planchenault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9600269A external-priority patent/FR2743562B1/en
Application filed by Individual filed Critical Individual
Publication of CA2241788A1 publication Critical patent/CA2241788A1/en
Application granted granted Critical
Publication of CA2241788C publication Critical patent/CA2241788C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (I) dans laquelle R1 à R9, R16 et R17 sont tels que définis à la revendication (1). Ces composés sont pharmacologiquement actifs.The invention relates to compounds of formula (I) in which R1 to R9, R16 and R17 are as defined in claim (1). These compounds are pharmacologically active.

CA002241788A 1996-01-11 1997-01-07 Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them Expired - Fee Related CA2241788C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/00269 1996-01-11
FR9600269A FR2743562B1 (en) 1996-01-11 1996-01-11 N- (ARYLSULFONYL) AMINO ACID DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/000026 WO1997025315A1 (en) 1996-01-11 1997-01-07 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity

Publications (2)

Publication Number Publication Date
CA2241788A1 true CA2241788A1 (en) 1997-07-17
CA2241788C CA2241788C (en) 2006-09-12

Family

ID=36999330

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002241788A Expired - Fee Related CA2241788C (en) 1996-01-11 1997-01-07 Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them

Country Status (1)

Country Link
CA (1) CA2241788C (en)

Also Published As

Publication number Publication date
CA2241788C (en) 2006-09-12

Similar Documents

Publication Publication Date Title
EP1334719A3 (en) Pentafluorobenzenesulfonamides and analogs
HUP0101999A2 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
FR2743562B1 (en) N- (ARYLSULFONYL) AMINO ACID DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
SE9904508D0 (en) New compounds
DE60103050D1 (en) SPIRO [2.4] HEPTANAMINOCARBONIC ACID AND ITS DERIVATIVES
RU94038064A (en) Derivatives of piperazine and piperidine, their use as antipsychotic agents, method of their synthesis, pharmaceutical composition
NO954072D0 (en) Water-soluble camptothecin derivatives, processes for their preparation and their use as antitumor agents
SE0102055D0 (en) New Compounds
ATE440838T1 (en) PHARMACEUTICALLY ACTIVE SULFONYLAMINOSIC ACID DERIVATIVES
BR9609847A (en) N- (4-Benzyl-substituted) -2-aminolactam derivatives
BR9503572A (en) Compound pharmaceutical composition and method of treatment or prevention of a disease
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
DE69819539D1 (en) ANTITHROMBOTIC AGENTS
RU94038042A (en) Derivatives of hexahydroazepine, pharmaceutical composition based on thereof and antipsychotropic agent
CA2107485A1 (en) Ellipticin derivatives, their preparation process and pharmaceutical compositions containing them
PE45195A1 (en) DERIVATIVE OF AMINO ACID, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT
CA2274133A1 (en) Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
CA2235421A1 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
MA26734A1 (en) 1-TRIFLUOROMETHYL -4-HYDROXY- 7-PIPERIDINYL- AMINOMETHYLCHROMANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2241788A1 (en) Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them
CA2308780A1 (en) Novel derivatives of 2,3-methanoamino acids, process for their preparation and pharmaceutical compositions containing them
CA2292248A1 (en) Novel derivatives of 1,2-dithiolane, process for preparing them and pharmaceutical compositions containing them
MX9603568A (en) Alkenyl-benzoylguanidine derivatives.
CA2235053A1 (en) Novel amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and 2,3-dihydro-cyclopenta[e]indene, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130107